MitoPharm Corporation’s Compound, Schisandrin B, Has Been Shown to Protect the Liver Against Chemical Toxin-Induced Damage

SEATTLE, WA--(MARKET WIRE)--Aug 23, 2007 -- MitoPharm Corporation, Inc. (Other OTC:MTPM.PK - News), a biotechnology company, today announces that one of the beneficial effects of Schisandrin B, the precursor of (-) Schisandrin B, is the protection of liver tissues.